Redefining
patient access

It's Time To Tell A Different Story About Patient Recruitment

We built the only platform teams need to execute their digital patient recruitment tasks, find patient-specific insights, get the support they need, and keep patients engaged – all from a single place

USED BY

Need help with a study?

By submitting your information you agree to our privacy notice

Automate Patient Recruitment with State of Art Data, Design and Delivery

ThE neucruit platform

The Dashboard

Maximize visibility with a single-source-of-truth for your patient recruitment. View advanced analytics on reach, conversion and demographics to optimize for efficiency, transparency and diversity.

How we deliver

We design compelling patient outreach strategies by using data and patient-centered design. Using proven methods in consumer technology, we’ve developed a highly optimised process that brings results in just a few weeks. Sound interesting?

IQOS

Over 87% reduction in enrolment timelines for smoking cessation study.

RAMP

670% increase in black minority ethnic participation in mood disorder study.

CNEM

Over 96% reduction in enrolment timelines for metabolic disorder study.

Case Study Coming Soon

NIHR

Geolocalisation and frequency mapping in Atopic Dermatitis study.

Case Study Coming Soon

NEURO

NLP to understand motivation to participate in Neuropathic Pain study.

We've needed the support mechanism for a long time

Group 2877
“I highly recommend. An outstanding vehicle to support recruiting for research studies. We’ve needed this support mechanism for a long time.”
Group 427323910
“The team are very responsive and friendly and assisted us with advertising our study to participants with specific demographics and who met our inclusion criteria. Thank you for your help!”
Group 427323911
“Neucruit were incredibly helpful while we set up our online study - providing useful, prompt, and friendly support. They also sent regular updates on recruitment and offered helpful advice regarding increasing respondent rates. We'd be happy to work with them again.”
Group 70
“Neucruit was incredibly useful in getting my study out there, and aided in getting me more participants for the last leg of my study, before my deadline. I'd highly recommend using them if you need help with recruiting for your study, or just getting people interested. I'll most likely be using Neucruit again if I do more research in the future.”
Group 427323913
“I think the team are very easy to work with and friendly! I would recommend them if you have tight recruitment deadlines.”
Group 427323914
Quick and effortless: a very reliable source for collecting data for our study. The set-up is quick and effortless, something that us researchers need more and more. I would definitely recommend them.
Group 427323915
A great platform for participant recruitment. They are great at following up and notifying us of other potential participant groups. Our working relationship has been flawless and the RAMP team would highly recommend using them as a route for recruiting participants into your study
Group 427323916
Collecting participants is always a daunting process. Neucruit made the process feasible. I'm very happy with the friendly customer service and effort from the team. Thank you!

Leading by Innovation

Less than 0.02% of companies were awarded by Innovate UK last year - we were one of them

Innovate UK 2021

A game-changing R&D innovation that can significantly impact the UK economy

UKRI 2020 Award

A catalyst in addressing diverse challenges in clinical research during the pandemic

EU Commission 2021

A breakthrough technology that will create new markets and scale up internationally

See the full picture


Access aggregated real-time data from over 25 million global data points
to inform your clinical trial strategy and solve for tomorrow’s challenges

Understand what’s happening today to plan for tomorrow

Access aggregated real-time data from over 25 million global data points to inform your clinical trial strategy and solve for tomorrow’s challenges.